Biological
Allogeneic Islets of Langerhans
Allogeneic Islets of Langerhans is a biological therapy with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_1
3
75%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 13 (100.0%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
unknown
Islet Transplant for Type 1 or Surgical Diabetes
NCT01606475
completedphase_1
MGA031, Sirolimus and Tacrolimus in Islet Transplantation
NCT00265473
completedphase_1
hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients
NCT00285194
completedphase_1
Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation
NCT00286624
Clinical Trials (4)
Showing 4 of 4 trials
NCT01606475
Islet Transplant for Type 1 or Surgical Diabetes
NCT00265473Phase 1
MGA031, Sirolimus and Tacrolimus in Islet Transplantation
NCT00285194Phase 1
hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients
NCT00286624Phase 1
Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4